Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q2 2015 · 10-Q
Revenue$0.00$0.00— vs Q2 2014 Net Income-$968.25K-$968.25KN/M vs Q2 2014 EPS Diluted$0.00$0.00— vs Q2 2014 Operating Income-$943,467N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$296,425— ended Jun 30, 2015 · filed Aug 11, 2015 · 42 d after period end